Chile's first cannabis-based medicine goes on sale
Cannabiol, the first cannabis-based medicine developed in Chile, has been put up for sale This week in a municipal pharmacy north of Santiago. It is designed to treat chronic pain resulting from neurological diseases or cancer.
Chile legalized medical cannabis in 2015, and was content until now to import its medical cannabis. In 2016, Sativex was also approved for sale.
Cannabiol was developed by a Chilean laboratory specializing in phytotherapy, Knop Laboratories, after obtaining a special permit from the Institut de Santé Publique (ISP) to distribute the drug.
The cannabis used in the production of this medicine comes from the 6,900 plants of the «Tierra Santa» plantation, in the town of Quinamávida (about 350 km south of Santiago), which belong to the Fundación Daya, which advocates the medical use of cannabis.
The Foundation has partnered with 15 municipalities to distribute the drug. Approximately 2,500 people in these towns will have access to Cannabiol, and a further 200 people have registered for PSI authorization.
Presented in oily form, it sells for 75$ per 30 mL.
In Chile, although private consumption is authorized, the sale of cannabis is still punishable. The Chilean Congress is currently debating a bill to regulate the consumption and self-cultivation of cannabis.
A THC:CBD oil shows promising results in reducing agitation in people with dementia
San Francisco Allows «Cannabis Cafés»
Kenya Denies Rastafarians the Right to Use Cannabis
German patients prefer medical cannabis with a high THC content
Curaleaf Is the First to Register Medical Cannabis Products in Spain
South Australia is working to identify more water-efficient hemp varieties
Massachusetts voters will vote in November on whether to repeal the legalization of cannabis
[Le trois-feuilles] The 2026 World Cup Provides a Global Showcase for Legal Cannabis
Wyoming Rejects the Reclassification of Cannabis
Medical Cannabis: The third edition of Science in the City will be held in Paris on September 28 and 29, 2026
-
Cannabis in France4 weeks agoFrance Sets July as the Deadline for the Widespread Adoption of Medical Cannabis
-
Cannabis in Europe2 weeks ago
Bosnia and Herzegovina Continues to Roll Out Medical Cannabis Following Its Legalization
-
Cannabis in France2 weeks ago
France Submits the Long-Awaited Decree on the Reimbursement of Medical Cannabis to the Council of State
-
Cannabis in the U.S.2 weeks ago
The DEA Begins Hearings on the Federal Rescheduling of Cannabis
-
Cannabis in Ireland3 weeks ago
The Irish Parliament recommends decriminalizing all drugs
-
Business4 weeks ago
Sanity Group is expanding its presence in Switzerland through a distribution agreement with Astrasana
-
Cannabis in France4 weeks ago
Medical Cannabis in France: What the First Major Study Reveals About Its Actual Impact
-
Cannabis in Switzerland3 weeks ago
St. Gallen, Switzerland, Launches Its 8th Legal Cannabis Pilot Project
You must be logged in to post a comment Login